v3.25.0.1

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Current assets:
Cash and cash equivalents	$ 681,000	$ 179,000
Inventory	11,000	0
Prepaid expenses	9,000	16,000
Total current assets	701,000	195,000
Equity method investment	1,000	1,000
Operating lease right-of-use asset	6,000	42,000
Other assets	10,000	10,000
Total assets	718,000	248,000
Current liabilities:
Accounts payable and accrued expenses	164,000	129,000
Accrued payroll and payroll taxes – related parties	434,000	414,000
Note payable	9,000	9,000
Operating lease liability, current portion	6,000	46,000
Total current liabilities	613,000	598,000
Note payable, non-current	128,000	130,000
Total liabilities	741,000	728,000
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and June 30, 2024	0	0
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 284,289,740 shares issued and outstanding as of December 31, 2024 and June 30, 2024	284,000	284,000
Additional paid-in capital	26,188,000	26,083,000
Accumulated deficit	(26,495,000)	(26,847,000)
Total stockholders’ deficit	(23,000)	(480,000)
Total liabilities and stockholders’ deficit	$ 718,000	$ 248,000

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Cavitation Technologies, Inc. 10-Q